Legacy perfluoro-alkyl substances impair LDL-cholesterol uptake independently from PCSK9-function.

Endocytosis Environmental exposure LDL-receptor Sphingosine Triglycerides

Journal

Toxicology reports
ISSN: 2214-7500
Titre abrégé: Toxicol Rep
Pays: Ireland
ID NLM: 101630272

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 11 10 2023
pubmed: 11 10 2023
entrez: 11 10 2023
Statut: epublish

Résumé

Perfluoro-alkyl substances (PFAS) are pollutants, whose exposure was associated with altered levels of low-density lipoproteins (LDL) in humans. Here we investigated this clinical outcome in two groups of young male adults residing in areas of respectively low and high environmental exposure to perfluoro-octanoic-acid (PFOA). From the Regional Authority data on pollution areas, 38 not-exposed and 59 exposed age-matched participants were evaluated for serum levels of total cholesterol (Total-Chol), LDL-Chol, high-density lipoprotein cholesterol (HDL-Chol), triglycerides (Tgl) and chromatography quantified PFOA. Human hepato-carcinoma cell line HepG2 was exposed to PFOA or perfluoro-octane-sulfonate (PFOS), as legacy PFAAs, and C6O4 as new generation compound. Fluorimetry was used to evaluate the cell-uptake of labelled-LDL. Proprotein Convertase Subtilisin/Kexin 9 (PCSK9)-mediated LDL-receptor (LDL-R) degradation and sub-cellular localization of LDL-R were evaluated by western blot analysis. Serum levels of PFOA, were positively and significantly correlated with Total-Chol (

Identifiants

pubmed: 37818225
doi: 10.1016/j.toxrep.2023.09.016
pii: S2214-7500(23)00108-7
pmc: PMC10560979
doi:

Types de publication

Journal Article

Langues

eng

Pagination

288-294

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Chemosphere. 2014 Mar;98:78-83
pubmed: 24238303
Environ Health. 2020 Mar 14;19(1):33
pubmed: 32169067
Eur Heart J. 2013 Dec;34(45):3478-90a
pubmed: 23956253
Environ Int. 2022 Jan;158:106982
pubmed: 34781208
Org Biomol Chem. 2005 Oct 21;3(20):3607-12
pubmed: 16211095
Toxicol Appl Pharmacol. 1999 Dec 1;161(2):209-18
pubmed: 10581215
Int J Mol Sci. 2020 Jan 08;21(2):
pubmed: 31936344
Ann Work Expo Health. 2023 Apr 21;67(4):518-535
pubmed: 36715212
PPAR Res. 2010;2010:
pubmed: 20936131
Toxicology. 2021 Jul;459:152845
pubmed: 34246716
Cell Rep. 2016 Nov 1;17(6):1532-1545
pubmed: 27806293
Sci Total Environ. 2022 Mar 25;814:152732
pubmed: 34974025
Cardiovasc Toxicol. 2005;5(2):91-4
pubmed: 16046786
Circ Res. 2006 Sep 29;99(7):692-705
pubmed: 17008598
Circulation. 2015 Oct 27;132(17):1667-78
pubmed: 26503749
Environ Int. 2021 Sep;154:106584
pubmed: 33895438
Environ Health Perspect. 2007 Sep;115(9):1298-305
pubmed: 17805419
Environ Sci Technol. 2008 Feb 15;42(4):995-1003
pubmed: 18351063
J Occup Environ Med. 2010 Mar;52(3):258-62
pubmed: 20190657
Front Endocrinol (Lausanne). 2021 Sep 03;12:632927
pubmed: 34539566
J Biol Chem. 2017 Feb 24;292(8):3074-3088
pubmed: 28049734
J Clin Endocrinol Metab. 2019 Apr 1;104(4):1259-1271
pubmed: 30403786
Environ Int. 2022 May;163:107198
pubmed: 35447437
Environ Health Perspect. 2023 May;131(5):56001
pubmed: 37141244
Toxicology. 2009 Nov 9;265(1-2):27-33
pubmed: 19751795
Nat Rev Cardiol. 2021 Oct;18(10):689-700
pubmed: 33833450
J Immunotoxicol. 2018 Dec;15(1):41-52
pubmed: 29514525
Atherosclerosis. 2018 Aug;275:273-295
pubmed: 29980055
Environ Sci Technol. 2022 Dec 6;56(23):17039-17051
pubmed: 36374530
Toxicology. 2017 Jul 15;387:95-107
pubmed: 28558994
Atherosclerosis. 2016 May;248:123-31
pubmed: 27016614
Environ Pollut. 2019 Apr;247:953-963
pubmed: 30823350
Crit Rev Toxicol. 2014 Jan;44(1):1-49
pubmed: 24180432
Int J Mol Sci. 2021 May 30;22(11):
pubmed: 34070931
PLoS One. 2015 Feb 18;10(2):e0117758
pubmed: 25693195
Eur Heart J. 2012 Jun;33(11):1360-6
pubmed: 22408029
Nat Rev Dis Primers. 2017 Dec 07;3:17093
pubmed: 29219151
Toxicology. 2017 Mar 01;378:37-52
pubmed: 28049043
Toxicol Sci. 2007 Oct;99(2):366-94
pubmed: 17519394

Auteurs

Iva Sabovic (I)

Unit of Andrology and Reproductive Medicine, Department of Medicine, University of Padova, Padova, Italy.

Maria Giovanna Lupo (MG)

Department of Medicine, University of Padova, Padova, Italy.

Ilaria Rossi (I)

Department of Medicine, University of Padova, Padova, Italy.

Federica Pedrucci (F)

Unit of Andrology and Reproductive Medicine, Department of Medicine, University of Padova, Padova, Italy.

Andrea Di Nisio (A)

Unit of Andrology and Reproductive Medicine, Department of Medicine, University of Padova, Padova, Italy.

Stefano Dall'Acqua (S)

Department of Pharmacological Sciences, University of Padova, Padova, Italy.

Nicola Ferri (N)

Department of Medicine, University of Padova, Padova, Italy.
Veneto Institute of Molecular Medicine, Padova, Italy.

Alberto Ferlin (A)

Unit of Andrology and Reproductive Medicine, Department of Medicine, University of Padova, Padova, Italy.

Carlo Foresta (C)

Unit of Andrology and Reproductive Medicine, Department of Medicine, University of Padova, Padova, Italy.

Luca De Toni (L)

Unit of Andrology and Reproductive Medicine, Department of Medicine, University of Padova, Padova, Italy.

Classifications MeSH